サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777547

シーケンシング消耗品の世界市場

Sequencing Consumables

出版日
ページ情報
英文 381 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
シーケンシング消耗品の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 381 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

シーケンシング消耗品の世界市場は2030年までに266億米ドルに到達

2024年に82億米ドルと推定されるシーケンシング消耗品の世界市場は、2024年から2030年にかけてCAGR 21.6%で成長し、2030年には266億米ドルに達すると予測されます。本レポートで分析したセグメントの一つであるキットは、CAGR23.6%を記録し、分析期間終了時には183億米ドルに達すると予測されます。試薬セグメントの成長率は、分析期間中CAGR17.3％と推定されます。

米国市場は22億米ドルと推定、中国はCAGR29.2％で成長予測

米国のシーケンシング消耗品市場は、2024年に22億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに64億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは29.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ17.0％と19.4％と予測されています。欧州では、ドイツがCAGR約18.1%で成長すると予測されています。

世界のシーケンシング消耗品市場- 主要動向と促進要因のまとめ

次世代シーケンシングが消耗品需要のかつてない増加を促進？

研究、臨床、産業の各領域で次世代シーケンサー（NGS）プラットフォームが広く採用されたことで、シーケンシング消耗品の需要が世界的に大幅に拡大しています。シーケンシング消耗品には、シーケンスワークフローに必要な試薬、フローセル、キット、酵素、その他のシングルユースアイテムが含まれ、ゲノムバリューチェーンの重要なバックボーンを形成しています。シーケンス技術のスループット、精度、アクセシビリティが向上するにつれて、消耗品の使用量は指数関数的に増加します。調査では、集団遺伝学、腫瘍学、エピジェネティクス、マイクロバイオーム解析などの大規模ゲノム研究が拡大し、高忠実度シーケンスキットと試薬を大量に消費しています。さらに、個別化医療がますます重視されるようになったため、臨床シーケンサーが牽引力を増しており、がん、希少疾患、感染症プロファイリング、薬理ゲノミクスなどの診断シーケンサーが増加しています。これらの使用事例にはそれぞれ、品質、感度、処理速度に対する独自の要件があり、汎用消耗品と用途別消耗品の両方が急増しています。さらに、シーケンシング装置の技術革新のペースが速いため、互換性のある消耗品も常に反復とアップグレードが繰り返され、複雑さが増し、需要が再燃しています。

自動化とワークフローの最適化が製品開発をどのように再定義しているか？

ラボの自動化と統合されたシーケンスワークフローの進歩は、消耗品を取り巻く期待を大きく変えました。バイオ医薬品の研究開発、学術ラボ、商業的シーケンスサービスプロバイダーのいずれにおいても、ハイスループットセッティングでは、スピード、一貫性、自動化システムとの互換性のために最適化された消耗品がますます好まれるようになっています。このシフトは特に、充填済み試薬カートリッジ、すぐに使えるサンプル調製キット、合理化されたライブラリー調製試薬の設計に表れており、人為的ミスや作業時間を減らすことができます。メーカーはまた、パッケージング形式、試薬の安定性、温度耐性においても革新的で、臨床ラボ、移動検査ユニット、小規模研究施設などの分散型シーケンス環境の運用ニーズに対応しています。さらに、シングルセルシーケンス、空間トランスクリプトミクス、マルチオミクスアプローチは、超高感度と特異性を備えた特殊な消耗品フォーマットの到来を告げています。これらの技術革新は、精密腫瘍学、神経遺伝学、病原体監視などの新たな使用事例をサポートする上で極めて重要です。エンド・ツー・エンドのワークフロー・ソリューションへの移行により、シーケンス機器メーカーは独自の消耗品に二の足を踏むようになり、最適な性能を確保しながらユーザーを特定のエコシステムに囲い込むようになっています。

世界の格差とサプライチェーンダイナミクスは市場の勢いに影響を与えるか？

研究資金、ヘルスケアインフラ、規制の枠組みにおける地理的な格差は、シーケンシング消耗品の採用に不均等なパターンを生み出しています。北米は、生物医学研究への旺盛な投資、遺伝子検査に対する有利な償還、ゲノミクス企業やシーケンシング技術リーダーの集積により、引き続きリードしています。欧州は、広範な精密医療への取り組みと官民パートナーシップが普及を促進し、僅差で続いています。一方、アジア太平洋地域は、中国、インド、日本におけるゲノムプログラムの拡大と、診断インフラや現地製造能力の向上に後押しされ、高成長地域として浮上しています。しかし、地政学的緊張、パンデミック関連の混乱、ロジスティクスの制限によって悪化したサプライチェーンの制約が、重要な消耗品のタイムリーな入手を妨げていることもあります。市場は、製造の地域化、在庫回復力の強化、サプライヤー・ネットワークの多様化といった取り組みで対応してきました。消耗品に含まれる使い捨てプラスチックや有害化学廃棄物をめぐる環境問題への懸念も、業界関係者に環境に優しい代替品や持続可能な生産モデルの探求を促しています。コストに敏感な市場を持つ地域では、性能とアクセシビリティのバランスが取れた、手頃な価格のモジュール式消耗品オプションへの需要が高まっており、段階的な製品ラインや地域ごとの価格戦略への道が開かれつつあります。

シーケンシング消耗品市場の急成長の原動力は？

シーケンシング消耗品市場の成長は、テクノロジーの進化、エンドユーザーの拡大、消費パターンの変化に直結するいくつかの要因によって牽引されています。第一に、高スループットシーケンサー、特にベンチトップおよびクリニカルグレードのプラットフォームの世界の普及が、コアラボとサテライトラボの両方における日常的な消耗品の使用を押し上げています。第二に、ロングリード、ナノポア、1分子シーケンシングなどの新しいシーケンシング技術の出現により、これらのプラットフォームに合わせた新しいカテゴリーの特殊な試薬やケミストリーキットに対する需要が生じています。第3に、農業、食品安全、法医学、獣医学など、シーケンス用途の多様化により、サンプル前処理、増幅、シーケンス用の消耗品に大きく依存する最終用途が新たに生まれています。第4に、特に感染症検出や新生児スクリーニングにおいて、分散型検査モデルやポイントオブケアシーケンスの普及が進んでいるため、携帯可能で安定した、使いやすい消耗品フォーマットのニーズが高まっています。第5に、エンドユーザーはより高いスループットと再現性を求めており、統合ラボエコシステムと互換性のある、バリデーション済みの自動化対応消耗品を好む傾向が強まっています。最後に、シーケンシングシステムメーカー間の競合は激化しており、消耗品は利益率の高い継続的な収益源として、独自の製品エコシステム、サブスクリプションモデル、付加価値サービスバンドルに関する積極的な戦略を促しています。これらの要因が相まって、シーケンシング消耗品は単なる補助的要素ではなく、より広範なゲノミクス市場において中心的な収益およびイノベーション促進要因として定着しつつあります。

セグメント

製品（キット、試薬、アクセサリー）、用途（がん診断、感染症診断、生殖医療診断、ファーマコゲノミクス、アグリゲノミクス、その他）、最終用途（製薬・バイオテクノロジー企業、病院・研究所、学術研究機関、その他）

調査対象企業の例

  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Beckman Coulter, Inc.
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Genomics
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech（Eurofins Genomics）
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invitrogen（Thermo Fisher Scientific）
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Macrogen Inc.
  • MGI Tech Co., Ltd.
  • Micronit
  • Millipore Sigma
  • New England Biolabs, Inc.
  • Nugen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Swift Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32908

Global Sequencing Consumables Market to Reach US$26.6 Billion by 2030

The global market for Sequencing Consumables estimated at US$8.2 Billion in the year 2024, is expected to reach US$26.6 Billion by 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 23.6% CAGR and reach US$18.3 Billion by the end of the analysis period. Growth in the Reagents segment is estimated at 17.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.2 Billion While China is Forecast to Grow at 29.2% CAGR

The Sequencing Consumables market in the U.S. is estimated at US$2.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2030 trailing a CAGR of 29.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.0% and 19.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.1% CAGR.

Global Sequencing Consumables Market - Key Trends & Drivers Summarized

Is Next-Generation Sequencing Fueling an Unprecedented Rise in Consumables Demand?

The widespread adoption of next-generation sequencing (NGS) platforms across research, clinical, and industrial domains has significantly amplified the demand for sequencing consumables worldwide. Sequencing consumables - which include reagents, flow cells, kits, enzymes, and other single-use items necessary for sequencing workflows - form a critical backbone of the genomic value chain. As the throughput, accuracy, and accessibility of sequencing technologies improve, consumable utilization scales exponentially, driven by the sheer volume of sequencing tests being performed across a growing array of applications. In research, expanding large-scale genomic studies such as population genetics, oncology, epigenetics, and microbiome analyses are consuming vast quantities of high-fidelity sequencing kits and reagents. Additionally, clinical sequencing is gaining traction due to the increasing emphasis on personalized medicine, leading to a rise in diagnostic sequencing for cancer, rare diseases, infectious disease profiling, and pharmacogenomics - all requiring specialized, clinical-grade consumables. Each of these use cases brings unique requirements for quality, sensitivity, and processing speed, prompting a surge in both general-purpose and application-specific consumables. Furthermore, the rapid pace of innovation in sequencing instrumentation is leading to constant iterations and upgrades in compatible consumables, adding layers of complexity and fueling recurrent demand.

How Are Automation and Workflow Optimization Redefining Product Development?

Advancements in laboratory automation and integrated sequencing workflows have significantly altered the expectations surrounding consumable products. In high-throughput settings, whether in biopharma R&D, academic labs, or commercial sequencing service providers, there is an increasing preference for consumables that are optimized for speed, consistency, and compatibility with automated systems. This shift is particularly visible in the design of pre-filled reagent cartridges, ready-to-use sample prep kits, and streamlined library preparation reagents that reduce human error and hands-on time. Manufacturers are also innovating in packaging formats, reagent stability, and temperature tolerance, catering to the operational needs of decentralized sequencing environments such as clinical labs, mobile testing units, and smaller research facilities. Moreover, single-cell sequencing, spatial transcriptomics, and multi-omics approaches are ushering in specialized consumable formats with ultra-high sensitivity and specificity. These innovations are critical in supporting emerging use cases like precision oncology, neurogenetics, and pathogen surveillance. The move toward end-to-end workflow solutions has made sequencing instrument manufacturers double down on proprietary consumables, locking users into specific ecosystems while ensuring optimal performance - a trend that, although controversial, is proving lucrative and strategically advantageous.

Can Global Disparities and Supply Chain Dynamics Influence Market Momentum?

Geographic disparities in research funding, healthcare infrastructure, and regulatory frameworks have created uneven patterns in sequencing consumables adoption. North America continues to lead due to robust investments in biomedical research, favorable reimbursement for genetic testing, and the concentration of genomics firms and sequencing technology leaders. Europe follows closely with extensive precision medicine initiatives and public-private partnerships driving uptake. Meanwhile, the Asia-Pacific region is emerging as a high-growth zone, fueled by expanding genomic programs in China, India, and Japan, alongside improvements in diagnostic infrastructure and local manufacturing capabilities. However, supply chain constraints - exacerbated by geopolitical tensions, pandemic-related disruptions, and logistics limitations - have occasionally hindered the timely availability of critical consumables. The market has responded with efforts to regionalize manufacturing, enhance inventory resilience, and diversify supplier networks. Environmental concerns surrounding single-use plastics and hazardous chemical waste in consumables are also prompting industry players to explore greener alternatives and sustainable production models. In regions with cost-sensitive markets, demand is growing for affordable, modular consumable options that balance performance with accessibility, paving the way for tiered product lines and localized pricing strategies.

What’s Driving the Surging Momentum in the Sequencing Consumables Market?

The growth in the sequencing consumables market is driven by several factors directly tied to technology evolution, end-user expansion, and changing consumption patterns. First, the increasing global adoption of high-throughput sequencers, particularly benchtop and clinical-grade platforms, is pushing up routine consumable usage in both core and satellite labs. Second, the emergence of novel sequencing techniques - including long-read, nanopore, and single-molecule sequencing - is generating demand for new categories of specialized reagents and chemistry kits tailored to these platforms. Third, the diversification of sequencing applications across agriculture, food safety, forensics, and veterinary sciences is creating new end-use verticals that rely heavily on consumables for sample prep, amplification, and sequencing. Fourth, the growing prevalence of decentralized testing models and point-of-care sequencing, particularly in infectious disease detection and newborn screening, is increasing the need for portable, stable, and user-friendly consumable formats. Fifth, end-users are demanding higher throughput and reproducibility, leading to increased preference for pre-validated, automated-ready consumables compatible with integrated lab ecosystems. Finally, competitive dynamics among sequencing system manufacturers have intensified, with consumables serving as a high-margin, recurring revenue stream - prompting aggressive strategies around proprietary product ecosystems, subscription models, and value-added service bundles. Together, these factors are cementing sequencing consumables not just as supporting elements but as central revenue and innovation drivers within the broader genomics market landscape.

SCOPE OF STUDY:

The report analyzes the Sequencing Consumables market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Reagents, Accessories); Application (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics, Others); End-Use (Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Beckman Coulter, Inc.
  • BGI Genomics
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurofins Genomics
  • F. Hoffmann-La Roche Ltd.
  • GATC Biotech (Eurofins Genomics)
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Invitrogen (Thermo Fisher Scientific)
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Macrogen Inc.
  • MGI Tech Co., Ltd.
  • Micronit
  • Millipore Sigma
  • New England Biolabs, Inc.
  • Nugen Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Swift Biosciences, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Sequencing Consumables - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Genomic Research and Personalized Medicine Throws the Spotlight on High-Throughput Sequencing Consumables
    • Rapid Expansion of Clinical Diagnostics Strengthens the Business Case for Scalable Sequencing Reagents and Kits
    • Growth of Cancer Genomics and Liquid Biopsy Applications Propels Demand for High-Fidelity Sample Prep Consumables
    • Here's How the Rise of Precision Medicine Is Driving Adoption of Next-Generation Sequencing (NGS) Workflows
    • Technological Innovations in Library Preparation and Target Enrichment Enhance Accuracy and Workflow Efficiency
    • Increasing Utilization of Sequencing in Infectious Disease Surveillance Expands the Addressable Consumables Market
    • Emergence of Portable and Point-of-Care Sequencers Spurs Growth in On-Demand Consumable Solutions
    • Integration of Automation and Robotics in Genomics Labs Drives Standardization and Consumable Throughput
    • Here's the Story Behind Biopharma's Rising Demand for Sequencing in Drug Discovery and Companion Diagnostics
    • Growth in Agricultural Genomics, Microbiome Research, and Environmental DNA Analysis Opens New Market Segments
    • Shift Toward Multi-Omics and Single-Cell Sequencing Drives Innovation in Consumable Chemistry and Format Design
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sequencing Consumables Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sequencing Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cancer Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cancer Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Reproductive Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Reproductive Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Agrigenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Agrigenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Sequencing Consumables by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Sequencing Consumables by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Sequencing Consumables by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Sequencing Consumables by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Sequencing Consumables by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Sequencing Consumables Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Product - Kits, Reagents and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Sequencing Consumables by Product - Kits, Reagents and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Sequencing Consumables by Product - Percentage Breakdown of Value Sales for Kits, Reagents and Accessories for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Sequencing Consumables by End-Use - Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Sequencing Consumables by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Laboratories, Academic Research Institutes and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Sequencing Consumables by Application - Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Sequencing Consumables by Application - Percentage Breakdown of Value Sales for Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Pharmacogenomics, Agrigenomics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION